Trimethobenzamide

Trimethobenzamide

SCHEMBL6683399

COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC.COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 1.00
DRD3 P35462 2/20 1.00
LMNA P02545 2/20 1.00
ACHE P22303 1/20 1.00
SLC6A2 P23975 1/20 1.00
CYP2C19 P33261 1/20 1.00
KCNH2 Q12809 1/20 1.00
SMN1; SMN2 Q16637 5/20 0.98
MAPK1 P28482 1/20 0.98
HRH3 Q9Y5N1 1/20 0.80
BRD4 O60885 1/20 0.58
KMT2A Q03164 1/20 0.58
ALDH1A1 P00352 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.55
HPGD P15428 2/20 0.54
NPC1 O15118 1/20 0.52
PKM P14618 1/20 0.52
KDM4E B2RXH2 1/20 0.50
RAB9A P51151 1/20 0.50
HSD17B10 Q99714 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethobenzamide SCHEMBL28858 1.00 DRD2 (1.00) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL4586290 0.99 DRD2 (0.98) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL4586216 0.99 SMN1; SMN2 (1.00) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL4586062 0.99 DRD2 (0.98) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL41339 0.99 SMN1; SMN2 (1.00) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL3059009 0.98 DRD2 (0.96) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL4586023 0.97 DRD2 (0.94) DRD2DRD3LMNAACHESLC6A2
Trimethobenzamide SCHEMBL4586233 0.96 DRD2 (0.92) DRD2DRD3LMNAACHESLC6A2
Itopride SCHEMBL311309 0.89 DRD2 (1.00) DRD2DRD3LMNAACHESLC6A2
Itopride SCHEMBL554675 0.88 DRD2 (0.98) DRD2DRD3LMNAACHESLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1471889-A2 ORAL PEDIATRIC TRIMETHOBENZAMIDE FORMULATIONS AND METHODS King Pharmaceuticals, Inc. (US) 2004-11-03 EP disclosed
WO-2003072021-A2 ORAL PEDIATRIC TRIMETHOBENZAMIDE FORMULATIONS AND METHODS KING PHARMACEUTICALS, INC. (US) 2003-09-04 WO disclosed